Mast cells and matrix degradation at sites of tumour invasion in rat mammary adenocarcinoma. by Dabbous, M. K. et al.
Br. J. Cancer (1986), 54, 459-465
Mast cells and matrix degradation at sites of tumour
invasion in rat mammary adenocarcinoma
M.Kh. Dabbous1, R. Walker2, L. Haney1, L.M. Carter1, G.L. Nicolson3
& D.E. Woolley2
'Department of Biochemistry and Periodontics, University of Tennessee, Memphis, The Health Science
Center, Memphis, TN, 38163, USA, 2Department ofMedicine, University Hospital ofSouth Manchester,
Manchester M20 8LR, UK, and 3Department of Tumour Biology, University of Texas, M.D. Anderson
Hospital and Tumour Institute, Houston, TX, 77030, USA.
Summary Significant numbers of mast cells have been demonstrated histologically around the periphery of
the invasive rat mammary adenocarcinoma 13672NF. The number of mast cells at microfoci along the
tumour:host tissue junction was significantly greater than that found in normal mammary tissues, and few
mast cells were detected within the tumour itself. Mast cell degranulation, often associated with disruption
and lysis of the connective tissue matrix, was a common feature in later stages of tumour proliferation. When
soluble products derived from purified rat peritoneal mast cells were added to monolayer cultures of rat
stromal fibroblasts or tumour cells they stimulated a significant increase in total collagenase production, and
the mast cell products were also capable of activating the latent collagenases thus produced. Histological
examination indicated that degradation of local collagenous matrix was a common feature of mast cell
degranulation, an observation possibly explained by the release of mast cell enzymes and/or the potential of
this cell to modulate the expression of collagenolytic activity by surrounding cells. These observations suggest
that, at least in some tumours, mast cells contribute to the connective tissue breakdown commonly associated
with tumour invasiveness and metastatic spread.
Since Erlich's (1879) first description of mast cells
and their association with some neoplasms,
numerous reports have appeared confirming their
peripheral distribution around a variety of human
and experimentally-induced tumours (Westphal,
1891; Sylven, 1945; Janes & McDonald, 1948;
Fisher & Fisher, 1965; Hartveit, 1981; Farnoush &
McKenzie, 1983,1984). Mast cells are widely distri-
buted in connective tissues and increased numbers
have been reported in lesions of hypersensitivity
and inflammatory granulomata. Although it has
been suggested that mast cells are important in
connective tissue disease (Smyth & Gum, 1958) and
allergic-inflammatory disease (Lewis & Austen,
1981), the functional significance of mast cells in
tumour locations has remained speculative. Their
ability to release heparin, histamine, proteinases,
prostaglandins and various mediators and chemo-
tactic factors by degranulation or carefully
controlled exocytosis suggests that mast cells have
important functions in cellular interactions and
matrix degradation.
Because of our interest in the mechanisms of
tumour invasion and metastasis, especially the cel-
lular interactions involved in matrix degradation,
we have focussed our attention on the tumour:host
interface or 'invasion zone' as illustrated by the
13762NF rat mammary adenocarcinoma (Neri et
al., 1982; Welch et al., 1983). We report here our
finding of numerous mast cells at the tumour
periphery, an observation frequently associated with
disruption or lysis of the local collagenous matrix.
Mast cells have been shown to contain soluble
products which stimulate fibroblasts to produce
increased amounts of collagenase (Yoffe et al.,
1984; Pilarisetti et al., 1983; Atkins et al., 1985),
and mast cell products also have the ability to
stimulate monocyte-macrophages to produce
interleukin-1 (Yoffe et al., 1985), a factor known to
stimulate collagenase production by various
mesenchymal cells (see Woolley et al., 1984). Since
mast cells apparently have the potential to
modulate collagenolysis (Woolley, 1984) we have
also examined and report here the in vitro effects of
soluble mast cell products on the collagenolytic
behaviour of rat stromal fibroblasts and tumour
cells.
Materials and methods
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Tumour cell line
Tumour cell clone, MTLn3, was obtained from the
rat 13762NF mammary adenocarcinoma and main-
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tained in alpha-modified minimum essential
medium (AMEM) supplemented with 10% heat
inactivated foetal calf serum, HIFCS, (Grand
Island Biological Co., Grand Island, NY) as
previously described (Neri & Nicolson, 1981; Neri
et al., 1982).
Fibroblast cultures
Normal rat skin fibroblasts (NRS) were established
from skin explants of syngeneic newborn rats. The
subsequent fibroblast monolayers were grown in
AMEM containing 10% HIFCS at 37°C in 5%
CO2 and 95% humidified air.
In vivo studies
Single cell suspensions of the tumour cells were
prepared in Dulbecco's phosphate buffered saline,
DPBS, (GIBCO). Tumour cells (5 x 105) were
injected s.c. into the mammary fat pad of pathogen-
free, female Fischer 344 rats, anaesthetised with
methoxyflurane. Surgical resection of tumour speci-
mens growing s.c. was carried out after 14, 18, 21,
25 and 32 days. At later stages the tumour cell
mass varied in size and shape, but often measured
more than 2cm in its greatest dimension.
Histology
Tumour specimens with surrounding host issues
were fixed for 2h in 1% formaldehyde and 0.25%
glutaraldehyde in 0.1M sodium cacodylate buffer
(pH 7.4) at 4°C, and rinsed in 0.15M cacodylate
buffer prior to acetone dehydration. The specimens
were embedded in JB-4 plastic (Polysciences,
Warrington, PA) at 4°C, and 2,jm sections were
cut with an LKB Historange microtome. Mast cells
were stained for naphthol-AS-aminocaproate or
naphthol-ASD-chloracetate esterase activity as
described previously (Bromley et al., 1984; Bromley
& Woolley, 1984). All sections were counterstained
with 0.25% azure II - 0.25% methylene blue in
0.25% borax, and micrographs were taken on a
Vickers M41 photoplan microscope using Kodak
Panatomic-X film and green filter.
Mast cellproducts (MCP)
Mast cells were collected from the peritoneal fluids
of syngeneic rats and purified by Percoll density
gradient centrifugation as described previously
(Beelen & Walker, 1985). After washing twice in
DPBS, the purity was established by toluidine blue
staining at >95% mast cells. The preparation was
adjusted at 8 x 106 cells ml-1 in 1 M NaCl and
extracted overnight at 4°C followed by sonication
for 10 sec. After centrifugation at 16,000 rpm for
75 min at 4°C, the resulting supernatant was stored
at -20°C as stock MCP.
Collagenase activity
Fibroblasts and tumour cells were grown in multi-
well trays (Coming, Corning, NY) containing
AMEM-5%HIFCS. This medium was removed and
replaced with AMEM-2%HIFCS with and without
a supplement of 2.5% (v/v) MCP. Media was
collected after 3 days, stored at -20°C, and
adjusted to 50mM tris (pH 7.5), 10mM CaCl2 and
0.2M NaCl prior to collagenase assay. For protein
determination, a cell lysate was prepared from each
well. Floating cells were collected from the centri-
fugation of the medium and DPBS, pooled and
returned to their respective wells. Total cell
densities were dissolved in 500M1 0.1 N NaOH/well
and protein concentrations were determined by the
Bio-Rad Protein Assay (Bio-Rad, Rockville Centre,
NY).
Collagenase was assayed by measuring the release
of soluble radioactive peptides from 30pl 14C-
glycine-labelled reconstituted gel of collagen fibrils
(Dabbous et al., 1983a) after 16h at 350C. One unit
of collagenase degrades 1 jg collagen min 1 at
35°C and data is expressed as cumulative units per
mg protein per 3 days of culture (Dabbous et al.,
1983b). Both fibroblast and tumour cell cultures
produced latent collagenase which was activated by
conventional trypsin treatment - 50,jgml-1 for 12
min followed by 125jgml-P of soybean trypsin
inhibitor. Activation of latent collagenase prepara-
tions by mast cell products was performed at 340C
for 10min or 4h, after which an inhibitor cocktail
of 1 mgml-1 soybean tryspin inhibitor, 10mM N-
ethyl maleimide and 1 mM phenyl methyl sulphonyl
fluoride was added.
All assays were performed in triplicate and
represent the mean value +s.e. Control assays
included: (1) buffer alone which routinely released
no more than 3% solubilisation of total counts
available, (2) mast cell products at the test dilution
which released approximately 6% of total counts,
and (3) trypsin (5jgml-1) which released no more
than 8% of total counts thereby confirming the
native integrity of the collagen substrate. The
enzyme activity released by both fibroblast and
tumour cell cultures was inhibited by the metal
chelator ethylene diamine tetra-acetic acid, and at
25°C produced the typical 3:4 cleavage product of
type I collagen monomers as described previously
(Dabbous et al., 1977; Woolley et al., 1984).
Results
Mast cells were found to be randomly dispersed inMAST CELLS AND TUMOUR INVASION 461
the connective tissue and between fat deposits of
normal rat mammary tissue and most frequently
around small blood vessels. In contrast the tumour
specimens showed a significant increase in the
numbers of mast cells which were predominantly
located in microfoci at the tumour:host interface or
'invasion zone', and within connective stromal
tissue adjacent to the tumour (Figure 1). Mast cell
degranulation was often observed at these sites and
was invariably associated with localised matrix de-
gradation (Figure 2), especially at later stages of
tumour growth.
Mast cells were infrequent in the main mass of
tumour cells up to day 25, and no sign of mast cell
granules was found within the tumour despite the
use of highly specific histochemical staining
techniques. However, mast cells were commonly
observed within the tumour cell mass after 32 days
of tumour growth and nearly all appeared intact,
suggesting that the presence of tumour cells per se
did not induce degranulation. Additionally, intact
mast cells were frequently observed alongside fibro-
blasts in the connective tissue stroma remote from
tumour cells. Thus the factors that bring about
local mast cell degranulation at some tumour:host
junctions remain uncertain.
The enzymatic mechanism of localised lysis of
connective tissue associated with mast cell degranu-
lation has been examined in vitro by studying the
effects of mast cell components on the collageno-
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Figure 1 Mast cells at the periphery of the rat mammary adenocarcinoma. (a) Photomicrograph of the
tumour:host tissue junction after 25 days. A local concentration of mast cells is shown in the connective
tissue adjacent to the periphery of the tumour cell (tc) mass. No mast cells were found intermixed with
tumour cells. Section stained for aminocaproate esterase. Bar=60rim. (b) Mast cells stained at the periphery
of a 21 day tumour specimen. A mixture of tumour cells and fibroblasts is shown together with intact mast
cells. Note the integrity of the surrounding local matrix compared to that surrounding the degranulated mast
cells shown in Figure 2. Section stained with chloracetate esterase and counter-stained with methylene blue-
azure II. Bar=20,pm.462 M. Kh. DABBOUS et al.
Figure 2 Mast cell degranulation at the invasion zone of the rat mammary adenocarcinoma. (a) Mast cells at
the tumour:host tissuejunction from a 21 day tumour specimen. Mast cells were not seen within the tumour
cell (tc) mass of this specimen, but accumulations of mast cells around the tumour periphery was a common
observation. Note loss of some connective tissue matrix in the microenvironment of the two mast cells
showing signs of degranulation. Stained with aminocaproate esterase and counterstained with methylene blue-
azure II. Bar=20pm. (b) Mast cell granules, stained for chloroacetate esterase, are shown scattered along the
host tissue:tumour cell (tc) junction. Note the localised lysis of matrix associated with this degranulation
(arrows). Bar= 15Hm.
lytic expression of cultured fibroblasts and tumour
cells. Exposure of these cells to soluble mast cell
products (MCP) produced a 7.9 and 12-fold
increase in total collagenase production for fibro-
blast and tumour cell cultures respectively (Table I).
MCP itself had no detectable collagenase activity.
Latent collagenase preparations derived from
cultures of MTLn3 tumour cells or from rat
stromal fibroblasts was effectively activated by
MCP (Table II). Moreover, the level of activation
produced by MCP was equivalent to that produced
by optimal trypsin treatments. Thus soluble mast
cell products not only had the capacity to stimulate
collagenase production by fibroblast and tumour
cells but also had the ability to activate the released
latent enzyme.
Discussion
Aggregation of mast cells at the periphery of
various tumours has long been recognised but their
functional significance at the tumour:host junction
remains unclear. Several studies have suggested a
protective role for mast cells against tumours. For
instance mouse mast cells were reported to be
cytotoxic to mouse artd rat fibrosarcomas (Farram
& Nelson, 1980) and the growth of pulmonary
metastases of B16 melanoma was observed in mast
cell-free mice but not in normal mice ((Schitteck et
al., 1985). Similarly an inverse correlation between
tumour incidence and tissue histamine levels was
reported for fibrosarcomas and Lewis lung
carcinomas (Burtin et al., 1985). The importance ofMAST CELLS AND TUMOUR INVASION 463
Table I Effect of rat mast cell products (MCP) on
collagenase production by rat fibroblasts and tumour
cells.
Collagenase activity
(Unitsmg - protein)
Fibroblasts (NRS)
Control culture 0.68+0.12
Culture+MCP 5.36+0.9a
Tumour Cells (MTLn3)
Control culture 0.36+0.03
Culture+MCP 4.3 +0.5a
Control culture medium+MCP <0.06
Conditioned culture medium, with and without added
MCP (2.5%, v/v), was assayed for total collagenase as
described in Methods. Data represent the mean values of
triplicate determinations +s.e.
ap<0.002; bp<0.001 (Student's t-test).
mast cells in local homeostasis, inflammation and
tumour surveillance is supported by many studies
(Lewis & Austin, 1981; Parwaresch et al., 1985),
but in direct contrast to the reports of a protective
role against tumours some investigators have
stressed an association between mast cells and rapid
tumour growth (Csaba et al., 1961; Farnoush &
McKenzie, 1983). Both heparin and histamine have
been reported to have mitogenic properties (Roche,
1985; Norrby, 1985; Norrby & Enestrom, 1985) and
Hartveit (1981) reported that mast cell degranu-
lation in human breast carcinomas was associated
with areas of infiltrative growth. Such diverse
findings suggest that a unitary explanation for the
functional significance of mast cells in tumour cell
invasion is unlikely. However, the 13762NF rat
mammary adenocarcinoma has several histological
similarities to human breast carcinomas (Hartveit,
1981; Hartveit & Sandstad, 1982; Hartveit et al.,
1984) and the studies reported here may therefore
be more relevant to the pathology of these
neoplasms.
Mast cell degranulation in the rat, elicited by
compound 48/80, was reported to induce local
proliferation of fibroblasts and mesothelial cells
with depletion of extracellular matrix as judged by
ultrastructural studies (Norrby & Enestrom, 1984).
Similarly in the present study at the later stages of
tumour growth an increasing frequency of mast cell
degranulation was associated with connective tissue
lysis and, significantly, the latter was never
observed around intact mast cells. The extent of
degranulation was variable, not only between dif-
ferent tumour specimens but also at different
locations in the same tumour. At present the
stimulus for degranulation has not been identified,
Table II Activation of latent collagenase derived from
rat fibroblasts (NRS) and tumour cells (MTLn3) by
exposure to rat mast cell products (MCP).
Collagenase activity
(Unitsmg 1 protein)
Fibroblasts (NRS)
Unactivated medium 0.32+0.05
+MCP 0.70+0.01a
Tumour cells (MTLn3) 0.12+0.03
+MCP 0.73+0.02a
MCP control+control <0.07
Latent collagenase preparations were assayed for
collagenase activity before and after exposure to MCP
(2.5% v/v) as described in Methods. Data represent mean
values of triplicate determinations +s.e.
'P<0.0005 (Student's t-test).
but the histological findings suggest a micro-
environmental response at the tumour:host
junction which possibly relate to local changes in
homeostasis.
The degradation or lysis of connective tissue asso-
ciated with mast cell degranulation may have several
explanations. It is known that mast cells release a
variety of proteolytic enzymes (Lagunoff, 1968;
Birkedal-Hansen et al., 1976; Keiser, 1980; Metcalfe
& kaliner, 1981; Schwartz, 1983) and the tryptase
of human mast cells, which is apparently resistant
to plasma antiproteinases (Schwartz et al., 1981),
may contribute to fibrinolysis (Schwartz et al.,
1985), matrix destruction and the activation of
cascade mechanisms. We have been unable to
demonstrate detectable levels of a true collagenase
in rat MCP, although the recent identification of
human mast cell elastase (Meier et al., 1985) could
conceivably contribute collagenolytic activity.
However, perhaps of greater relevance to in vivo
collagenolysis is the finding that mast cell products
significantly stimulated collagenase production by
stromal fibroblast and tumour cell cultures, an
observation previously reported for synovial fibro-
blasts (Yoffe et al., 1984). As yet the stimulatory
factor has not been identified, but the response of
tumour cell lines to mast-cell mediated stimulation
of collagenolysis appears to be related to the meta-
static potential of the tumour cell (Dabbous et al.,
1986). The MCP preparations used in this study
also proved effective activators for latent colla-
genases derived from fibroblast and tumour cells,
presumably mediated via mast cell proteases as
described previously (Birkedal-Hansen et al., 1976).
Thus the potential for MCP to stimulate latent
collagenase production by surrounding fibroblasts
or tumour cells, and subsequently to activate the464 M. Kh. DABBOUS et al.
released precursor, provides one effective
mechanism for the generation of local collageno-
lytic activity. Another pathway is suggested by the
report that macrophages are stimulated by MCP,
probably heparin, to produce increased amounts of
interleukin-1 (Yoffe et al., 1985), a factor known to
stimulate collagenase production by fibroblasts and
tumour cells (Henry et al., 1983).
Many studies have examined the role of colla-
genolytic enzymes in tumour invasion and metas-
tatic spread (for reviews see Woolley et al., 1980;
Liotta et al., 1982; Woolley, 1984) and recently
several investigations have emphasised the impor-
tance of tumour:host cell interactions in connective
tissue degradation (Tarin, 1976; Dabbous et al.,
1977,1983a,b; Biswas, 1982; Henry et al., 1983).
The tumour:host interface or 'invasion zone'
(Strauli, 1980) of many invasive tumours is variable
with regard to the type and relative numbers of
host cells. Previous immunolocalisation studies have
demonstrated that collagenase production at the
tumour edge is often microenvironmental in nature,
but the cellular origin of the enzyme may depend to
some extent on the type or tissue location of the
invasive tumour (Woolley, 1982; Woolley &
Grafton, 1980; Barsky et al., 1983). Further enzyme
localisation studies in conjunction with the identifi-
cation of specific host cells should help to elucidate
which cellular interactions are involved in
generating local collagenolysis in vivo. However, at
present our histological findings suggest that
degradation of local collagenous matrix is a
common feature of mast cell degranulation, an
observation possibly related to the release of mast
cell enzymes and/or the potential of this cell to
modulate the expression of collagenolytic activity
by surrounding cells.
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